TW201636032A - 使用前驅細胞治療眼睛病況 - Google Patents

使用前驅細胞治療眼睛病況 Download PDF

Info

Publication number
TW201636032A
TW201636032A TW104140661A TW104140661A TW201636032A TW 201636032 A TW201636032 A TW 201636032A TW 104140661 A TW104140661 A TW 104140661A TW 104140661 A TW104140661 A TW 104140661A TW 201636032 A TW201636032 A TW 201636032A
Authority
TW
Taiwan
Prior art keywords
cells
cell
derived
umbilical cord
tsp
Prior art date
Application number
TW104140661A
Other languages
English (en)
Chinese (zh)
Inventor
伊恩 哈里斯
娜汀 德吉內卡
Original Assignee
健生生物科技公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 健生生物科技公司 filed Critical 健生生物科技公司
Publication of TW201636032A publication Critical patent/TW201636032A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW104140661A 2014-12-05 2015-12-04 使用前驅細胞治療眼睛病況 TW201636032A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462088429P 2014-12-05 2014-12-05
US201562126370P 2015-02-27 2015-02-27
US201562220873P 2015-09-18 2015-09-18

Publications (1)

Publication Number Publication Date
TW201636032A true TW201636032A (zh) 2016-10-16

Family

ID=56092673

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104140661A TW201636032A (zh) 2014-12-05 2015-12-04 使用前驅細胞治療眼睛病況

Country Status (16)

Country Link
US (1) US20160158293A1 (cg-RX-API-DMAC10.html)
EP (1) EP3258946A4 (cg-RX-API-DMAC10.html)
JP (1) JP2017537702A (cg-RX-API-DMAC10.html)
KR (1) KR20170093178A (cg-RX-API-DMAC10.html)
CN (1) CN107206028A (cg-RX-API-DMAC10.html)
AU (1) AU2015358330A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017011513A2 (cg-RX-API-DMAC10.html)
CA (1) CA2969690A1 (cg-RX-API-DMAC10.html)
HK (1) HK1250329A1 (cg-RX-API-DMAC10.html)
MX (1) MX2017007207A (cg-RX-API-DMAC10.html)
PH (1) PH12017500998A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017123184A (cg-RX-API-DMAC10.html)
SG (1) SG11201704268TA (cg-RX-API-DMAC10.html)
TW (1) TW201636032A (cg-RX-API-DMAC10.html)
WO (1) WO2016090215A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704521B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
JP7348892B2 (ja) * 2019-12-30 2023-09-21 佛教慈濟醫療財團法人 眼疾患を予防または治療する組成物及び方法
WO2021207282A2 (en) * 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
ES2569780T3 (es) * 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
CA2761610C (en) * 2009-05-13 2020-12-29 Medipost Co., Ltd. Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
CN103998048A (zh) * 2011-07-11 2014-08-20 车比奥及戴奥斯泰有限公司 脐带提取物的制备方法和使用方法
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Also Published As

Publication number Publication date
MX2017007207A (es) 2018-01-30
BR112017011513A2 (pt) 2018-07-10
RU2017123184A3 (cg-RX-API-DMAC10.html) 2019-07-17
CN107206028A (zh) 2017-09-26
US20160158293A1 (en) 2016-06-09
EP3258946A4 (en) 2018-08-01
PH12017500998A1 (en) 2017-12-18
SG11201704268TA (en) 2017-06-29
ZA201704521B (en) 2019-01-30
JP2017537702A (ja) 2017-12-21
KR20170093178A (ko) 2017-08-14
WO2016090215A2 (en) 2016-06-09
RU2017123184A (ru) 2019-01-10
HK1250329A1 (zh) 2018-12-14
CA2969690A1 (en) 2016-06-09
AU2015358330A1 (en) 2017-06-08
EP3258946A2 (en) 2017-12-27

Similar Documents

Publication Publication Date Title
US7413734B2 (en) Treatment of retinitis pigmentosa with human umbilical cord cells
AU2012217782B2 (en) Treatment of amyotrophic lateral sclerosis using umbilical derived cells
TW201632620A (zh) 使用前驅細胞治療視網膜變性
US20180344777A1 (en) Method of modulating müller glia cells
US20160158293A1 (en) Treatment of Ocular Conditions Using Progenitor Cells
US20180015129A1 (en) Treatment of retinal vascular disease using progenitor cells
TW201836623A (zh) 使用前驅細胞治療視網膜變性
TW201729819A (zh) 使用前驅細胞治療視網膜變性